Status:
COMPLETED
Obstructive Sleep Apnea Airway Evaluation
Lead Sponsor:
University Health Network, Toronto
Collaborating Sponsors:
Hospital for Special Surgery, New York
Conditions:
Obstructive Sleep Apnea
Eligibility:
All Genders
18+ years
Brief Summary
Current practice guidelines recommend obstructive sleep apnea (OSA) patients to stay in the post anesthetic care unit (PACU) until the risk of respiratory depression has subsided. Inevitably, a greate...
Detailed Description
The investigators plan to recruit surgical patients at risk of OSA, exposed to sedatives,and/or general anesthesia. Surface ultrasound measurements will be conducted in a separate setting, and be corr...
Eligibility Criteria
Inclusion
- Inclusion criteria
- age≥18
- ASA physical status I - IV;
- Suspected to have OSA for clinical reasons such as high risk on screening questionnaire i.e., a STOP-Bang score \>3, and referred to have a sleep study for OSA diagnosis by the clinical team at any point of care during the perioperative period (such as the clinic using the screening tool, during or after surgery in the ward experiencing recurrent upper airway obstructive events, need for CPAP in the postoperative period and / or suspected to have obstructive airway events). Or;
- Patients who were recently diagnosed to have OSA and underwent a laboratory sleep study within the last year.
- Patients who were recently diagnosed to have OSA but are non-compliant with treatment. Compliance defined as: median nightly CPAP or APAP use \> 70% of the nights, and for longer than 4 hours of nightly use during the last 3 months),43 or using oral appliance use (use \> 70% of nights, and for longer than 4 hours of nightly use in the last 3 months.
- Exclusion criteria
- failure to understand and provide consent
- past history of oral, head and neck surgery (e.g., OSA corrective surgery)
- active head \& neck disease (e.g., cancer, infection and radiotherapy);
- inability to perform breathing tests per instruction
- Patients currently on treatment for OSA (as this may interfere with the upper airway dimensions and the US assessment may not be accurate)
Exclusion
Key Trial Info
Start Date :
July 20 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2022
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03361553
Start Date
July 20 2017
End Date
September 30 2022
Last Update
December 11 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Toronto Western Hospital
Toronto, Ontario, Canada